These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1972 related articles for article (PubMed ID: 15900045)

  • 1. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Kaaks R; Berrino F; Key T; Rinaldi S; Dossus L; Biessy C; Secreto G; Amiano P; Bingham S; Boeing H; Bueno de Mesquita HB; Chang-Claude J; Clavel-Chapelon F; Fournier A; van Gils CH; Gonzalez CA; Gurrea AB; Critselis E; Khaw KT; Krogh V; Lahmann PH; Nagel G; Olsen A; Onland-Moret NC; Overvad K; Palli D; Panico S; Peeters P; Quirós JR; Roddam A; Thiebaut A; Tjønneland A; Chirlaque MD; Trichopoulou A; Trichopoulos D; Tumino R; Vineis P; Norat T; Ferrari P; Slimani N; Riboli E
    J Natl Cancer Inst; 2005 May; 97(10):755-65. PubMed ID: 15900045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
    Eliassen AH; Missmer SA; Tworoger SS; Spiegelman D; Barbieri RL; Dowsett M; Hankinson SE
    J Natl Cancer Inst; 2006 Oct; 98(19):1406-15. PubMed ID: 17018787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
    Tworoger SS; Missmer SA; Barbieri RL; Willett WC; Colditz GA; Hankinson SE
    J Natl Cancer Inst; 2005 Apr; 97(8):595-602. PubMed ID: 15840882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition.
    Kaaks R; Rinaldi S; Key TJ; Berrino F; Peeters PH; Biessy C; Dossus L; Lukanova A; Bingham S; Khaw KT; Allen NE; Bueno-de-Mesquita HB; van Gils CH; Grobbee D; Boeing H; Lahmann PH; Nagel G; Chang-Claude J; Clavel-Chapelon F; Fournier A; Thiébaut A; González CA; Quirós JR; Tormo MJ; Ardanaz E; Amiano P; Krogh V; Palli D; Panico S; Tumino R; Vineis P; Trichopoulou A; Kalapothaki V; Trichopoulos D; Ferrari P; Norat T; Saracci R; Riboli E
    Endocr Relat Cancer; 2005 Dec; 12(4):1071-82. PubMed ID: 16322344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association of plasma DHEA and DHEA sulfate with breast cancer risk in predominantly premenopausal women.
    Tworoger SS; Missmer SA; Eliassen AH; Spiegelman D; Folkerd E; Dowsett M; Barbieri RL; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):967-71. PubMed ID: 16702378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.
    Missmer SA; Eliassen AH; Barbieri RL; Hankinson SE
    J Natl Cancer Inst; 2004 Dec; 96(24):1856-65. PubMed ID: 15601642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer.
    Krajcik RA; Borofsky ND; Massardo S; Orentreich N
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1566-73. PubMed ID: 12496045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).
    Beattie MS; Costantino JP; Cummings SR; Wickerham DL; Vogel VG; Dowsett M; Folkerd EJ; Willett WC; Wolmark N; Hankinson SE
    J Natl Cancer Inst; 2006 Jan; 98(2):110-5. PubMed ID: 16418513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of sex hormones and breast cancer risk in premenopausal women: a case-control study (USA).
    Sturgeon SR; Potischman N; Malone KE; Dorgan JF; Daling J; Schairer C; Brinton LA
    Cancer Causes Control; 2004 Feb; 15(1):45-53. PubMed ID: 14970734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of serum dehydroepiandrosterone (DHEA), DHEA sulfate, and 5-androstene-3 beta, 17 beta-diol to risk of breast cancer in postmenopausal women.
    Dorgan JF; Stanczyk FZ; Longcope C; Stephenson HE; Chang L; Miller R; Franz C; Falk RT; Kahle L
    Cancer Epidemiol Biomarkers Prev; 1997 Mar; 6(3):177-81. PubMed ID: 9138660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma adrenal androgens and risk of breast cancer in premenopausal women.
    Page JH; Colditz GA; Rifai N; Barbieri RL; Willett WC; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):1032-6. PubMed ID: 15184260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk.
    Dorgan JF; Longcope C; Stephenson HE; Falk RT; Miller R; Franz C; Kahle L; Campbell WS; Tangrea JA; Schatzkin A
    Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):533-9. PubMed ID: 8827358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum sex hormone levels in pre- and postmenopausal breast cancer patients.
    Ho CC; Rohaizak M; Zulkifli SZ; Siti-Aishah MA; Nor-Aini U; Sharifah-Noor-Akmal SH
    Singapore Med J; 2009 May; 50(5):513-8. PubMed ID: 19495523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era.
    Platz EA; Leitzmann MF; Rifai N; Kantoff PW; Chen YC; Stampfer MJ; Willett WC; Giovannucci E
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1262-9. PubMed ID: 15894683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective study of estradiol and breast cancer in Japanese women.
    Kabuto M; Akiba S; Stevens RG; Neriishi K; Land CE
    Cancer Epidemiol Biomarkers Prev; 2000 Jun; 9(6):575-9. PubMed ID: 10868691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous sex hormones and prostate cancer risk: a case-control study nested within the Carotene and Retinol Efficacy Trial.
    Chen C; Weiss NS; Stanczyk FZ; Lewis SK; DiTommaso D; Etzioni R; Barnett MJ; Goodman GE
    Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1410-6. PubMed ID: 14693730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adiposity and sex hormones in girls.
    Baer HJ; Colditz GA; Willett WC; Dorgan JF
    Cancer Epidemiol Biomarkers Prev; 2007 Sep; 16(9):1880-8. PubMed ID: 17855709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated levels of circulating insulin-like growth factor-I, IGF-binding globulin-3 and testosterone predict hormone-dependent breast cancer in postmenopausal women: a case-control study.
    Kahán Z; Gardi J; Nyári T; Földesi I; Hajnal-Papp R; Ormándi K; Lázár G; Thurzó L; Schally AV
    Int J Oncol; 2006 Jul; 29(1):193-200. PubMed ID: 16773200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum concentrations of estrogens, sex hormone binding globulin, and androgens and risk of breast hyperplasia in postmenopausal women.
    Schairer C; Hill D; Sturgeon SR; Fears T; Mies C; Ziegler RG; Hoover RN; Sherman ME
    Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1660-5. PubMed ID: 16030098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Joint effect of insulin-like growth factors and sex steroids on breast cancer risk.
    Yu H; Shu XO; Li BD; Dai Q; Gao YT; Jin F; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2003 Oct; 12(10):1067-73. PubMed ID: 14578144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 99.